Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2147642
Reference Type
Journal Article
Subtype
Abstract
Title
Subacute 2-AAF toxicity in C57BL/6 and BALB/c strain mice
Author(s)
Schieferstein, G; Haley, TJ
Year
1974
Is Peer Reviewed?
1
Journal
Toxicology and Applied Pharmacology
ISSN:
0041-008X
EISSN:
1096-0333
Volume
29
Issue
1
Page Numbers
105
Language
English
Relationship(s)
is part of a larger document
3378179
Abstracts of papers for the Thirteenth Annual Meeting of the Society of Toxicology, Washington, D.C. March 10–14, 1974
Abstract
Ninety-day subacute toxicity of 2-acetylaminofluorene (2-AAF) has been determined in 1200 mice each of the C57BL/6 and BALB/c strains equally divided between the sexes. The concentrations of 2-AAF were 0.05, 0.025, 0.01, 0.005 and 0.001% of the diet. No signs of toxicity were seen. Slight weight reduction was seen in the C57BL/6 males and BALB/c females at the 0.05% AFF level. A dose-dependent urinary bladder epithelial hyperplasia was seen in both strains and the males were more susceptible than the females. Squamous metaplasia of the uroepithelium was observed in the BALB/c mice with this effect greater in the males. One BALB/c male at the 0.025 and 0.05% levels had bladder carcinoma. Adrenal gland spindle cell hyperplasia was greater in the females of both strains. Bladder concretions were observed in males of both strains. No other significant histopathological changes were observed. The data obtained will be utilized in the design of the large chronic studies to be conducted at NCTR.
Conference Name
Thirteenth Annual Meeting of the Society of Toxicology
Conference Location
Washington, D.C.
Conference Dates
March 10–14, 1974
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity